- English (USA)
- English (UK)
- English (India)
- English (Canada)
- English (Australia)
- English (Philippines)
- English (Nigeria)
- Deutsch
- Español (España)
- Español (México)
- Français
- Italiano
- Nederlands
- Polski
- Português (Portugal)
- Português (Brasil)
- Русский
- Türkçe
- العربية
- Ελληνικά
- Svenska
- Suomi
- עברית
- 日本語
- 한국어
- 简体中文
- 繁體中文
- Bahasa Indonesia
- Bahasa Melayu
- ไทย
- Tiếng Việt
- हिंदी
Molbio Diagnostics Ltd (MOLB)
Molbio Diagnostics Ltd stock price live, this page displays NSE MOLB stock exchange data. View the MOLB premarket stock price ahead of the market session or assess the after hours quote. Monitor the latest movements within the Molbio Diagnostics Ltd real time stock price chart below.
What Is the Molbio Diagnostics Ltd Stock Price Today?
The Molbio Diagnostics Ltd stock price today is 1 438,00.
What Is the Stock Symbol for Molbio Diagnostics Ltd?
The stock symbol for Molbio Diagnostics Ltd is "MOLB."
What Stock Exchange Does Molbio Diagnostics Ltd Trade On?
Molbio Diagnostics Ltd is listed and trades on the NSE stock exchange.
Is Molbio Diagnostics Ltd a Good Stock to Buy?
Determining whether Molbio Diagnostics Ltd—or any stock—is a good buy requires comprehensive analysis. To evaluate its potential, users can sign up to InvestingPro, where they can assess stock price fair value and other essential metrics.
You can find more details by visiting the additional pages to view historical data, charts, latest news, analysis or visit the forum to view opinions on the MOLB quote. (ISIN: INE869T01028)
What Is the Molbio Diagnostics Ltd Stock Price Today?
The Molbio Diagnostics Ltd stock price today is 1 438,00.
What Is the Stock Symbol for Molbio Diagnostics Ltd?
The stock symbol for Molbio Diagnostics Ltd is "MOLB."
What Stock Exchange Does Molbio Diagnostics Ltd Trade On?
Molbio Diagnostics Ltd is listed and trades on the NSE stock exchange.
Is Molbio Diagnostics Ltd a Good Stock to Buy?
Determining whether Molbio Diagnostics Ltd—or any stock—is a good buy requires comprehensive analysis. To evaluate its potential, users can sign up to InvestingPro, where they can assess stock price fair value and other essential metrics.
You can find more details by visiting the additional pages to view historical data, charts, latest news, analysis or visit the forum to view opinions on the MOLB quote. (ISIN: INE869T01028)
1,438.00
-136.40(-8.66%)
Closed·
Fair Value
An estimate of a stock's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Day's Range
1,415.00
1,570.90
52 wk Range
807.00
1,686.80
MOLBIO is not included in our AI-picked strategies. See which stocks are.
Fair Value
An estimate of a stock's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Day's Range
1,415.001,570.90
52 wk Range
807.001,686.80
Key Statistics
Edit
Prev. Close
Open
Volume
Average Volume (3m)
1-Year Change
Fair Value
UnlockFair Value Upside
UnlockMarket Cap
Shares Outstanding
Revenue
Net Income
EPS
EPS Growth Forecast
UnlockNext Earnings Date
Dividends Payment Streak
UnlockP/E Ratio
Return on Assets
Return on Equity
Gross Profit Margin
Price/Book
EBITDA
EV/EBITDA
Beta
Book Value / Share
Prev. Close
Open
Volume
Average Volume (3m)
1-Year Change
Fair Value
UnlockFair Value Upside
UnlockMarket Cap
Shares Outstanding
Revenue
Net Income
EPS
EPS Growth Forecast
UnlockNext Earnings Date
Dividends Payment Streak
UnlockP/E Ratio
Return on Assets
Return on Equity
Gross Profit Margin
Price/Book
EBITDA
EV/EBITDA
Beta
Book Value / Share
MOLBIO Scorecard
Company’s Health
Assesses a company's financial position by analysing its market value, financial ratios, industry benchmarks, and competitors.
UnlockFair Value
An estimate of a stock's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Unlock PriceTechnical Analysis
Neutral
Analysts Sentiment
Strong Buy
Price Target
1,650.00
Upside
+14.74%
Members' Sentiments
Bearish
Bullish
ProTips
Tips that distill complex financial data into concise, actionable investment insights.
Trading at a high earnings multiple
Technical Analysis
Summary
Strong Sell
Sell
Neutral
Buy
Strong Buy
Strong Sell
Technical Indicators
Strong Sell
Moving Averages
Strong Sell
Analyst Ratings
3 Buy
0 Hold
0 Sell
Ratings:
3 analysts
Overall Consensus
Strong Buy
Analysts 12-Month Price Target:
Average 1,650.00
(+14.74% Upside)
Earnings
Latest Release
Sep 05, 2026
EPS / Forecast
5,21 / --
Revenue / Forecast
4,08B / --
Compare MOLBIO to Peers and Sector
Metrics to compare | MOLBIO | Sector Sector - Average of metrics from a broad group of related Healthcare sector companies | Relationship RelationshipMOLBIOPeersSector | |
|---|---|---|---|---|
P/E Ratio | 72.8x | 20.8x | −0.3x | |
PEG Ratio | - | 0.19 | 0.00 | |
Price/Book | 15.5x | 1.3x | 2.6x | |
Price / LTM Sales | 10.3x | 0.6x | 2.9x | |
Upside (Analyst Target) | 4.8% | 15.1% | 66.7% | |
Fair Value Upside | Unlock | 19.9% | 9.6% | Unlock |
Molbio Diagnostics Limited, a point-of-care diagnostics company, provides healthcare technologies to diagnose infectious and non-communicable diseases. It manufactures and sells chip based diagnostic devices, chips and reagents, X-ray equipment's, and single/dual detectors. It also offers disposable POCT devices, which includes dengue, malaria, and COVID-19 tests; Tabletop analysers, a portable machine that are used to perform molecular or immunodiagnostic tests to detect infectious diseases, such as tuberculosis, human papillomavrus, STIs, and GI disorders. In addition, the company offers Truenat, a multi-disease real-time polymerase chain reaction platform that enables treatment decisions for various infectious and non-communicable diseases, such as tuberculosis, human immunodeficiency virus, malaria, viral hepatitis, COVID-19, dengue, chikungunya, influenza, H1N1, HPV/cervical cancer, cholera, leprosy, etc.; and Truenat assays. The company was incorporated in 2000 and is based in Verna, India.
Ownership
Ownership Overview
Top Holders
FAQ
What Is the Molbio Diagnostics (MOLBIO) Stock Price Today?
The Molbio Diagnostics stock price today is 1 438,00 INR.
What Stock Exchange Does Molbio Diagnostics Trade On?
Molbio Diagnostics is listed and trades on the India National Stock Exchange.
What Is the Stock Symbol for Molbio Diagnostics?
The stock symbol for Molbio Diagnostics is "MOLBIO."
What Is the Molbio Diagnostics Market Cap?
As of today, Molbio Diagnostics market cap is 181,43B INR.
What Is Molbio Diagnostics's Earnings Per Share (TTM)?
The Molbio Diagnostics EPS (TTM) is 22,10.
From a Technical Analysis Perspective, Is MOLBIO a Buy or Sell?
Based on moving averages and other technical indicators, the daily buy/sell signal is Neutral.
How Many Times Has Molbio Diagnostics Stock Split?
Molbio Diagnostics has split 0 times.
How Many Employees Does Molbio Diagnostics Have?
Molbio Diagnostics has 1225 employees.
What is the current trading status of Molbio Diagnostics (MOLBIO)?
As of Oct 19, 2026, Molbio Diagnostics (MOLBIO) is trading at a price of 1 438,00 INR, with a previous close of 1 574,40 INR. The stock has fluctuated within a day range of 1 415,00 INR to 1 570,90 INR, while its 52-week range spans from 807,00 INR to 1 686,80 INR.
What Is Molbio Diagnostics (MOLBIO) Price Target According to Analysts?
The average 12-month price target for Molbio Diagnostics is 1 650,00 INR, with a high estimate of 1800 INR and a low estimate of 1550 INR. 3 analysts recommend buying the stock, while 0 suggest selling, leading to an overall rating of Strong Buy. The stock has an +14,74% Upside potential.
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2026 - Fusion Media Limited. All Rights Reserved.